Fabrazyme® (agalsidase beta)
for Fabry Disease

Fabrazyme (agalsidase beta) is an enzyme replacement therapy used to treat Fabry disease in adults and children aged two years and older. It is a synthetic form of the alpha-galactosidase A enzyme, which helps reduce the buildup of globotriaosylceramide (GL-3) in the kidneys and other cells, preventing disease complications.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Fabry Disease